Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Laakso, A; Bergman, J; Haaparanta, M; Vilkman, H; Solin, O; Syvalahti, E; Hietala, J
   Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia
   SCHIZOPHRENIA RESEARCH
   
   A. Laakso et al., "Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia", SCHIZOPHR R, 52(1-2), 2001, pp. 115-120
2. Laakso, MP; Tiihonen, J; Syvalahti, E; Vilkman, H; Laakso, A; Alakare, B; Rakkolainen, V; Salokangas, RKR; Koivisto, E; Hietala, J
   A morphometric MRI study of the hippocampus in first-episode, neuroleptic-naive schizophrenia
   SCHIZOPHRENIA RESEARCH
   
   M.P. Laakso et al., "A morphometric MRI study of the hippocampus in first-episode, neuroleptic-naive schizophrenia", SCHIZOPHR R, 50(1-2), 2001, pp. 3-7
3. Laine, TPJ; Ahonen, A; Rasanen, P; Pohjalainen, T; Tiihonen, J; Hietala, J
   The A1 allele of the D-2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics
   ALCOHOL AND ALCOHOLISM
   
   T.P.J. Laine et al., "The A1 allele of the D-2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics", ALC ALCOHOL, 36(3), 2001, pp. 262-265
4. Hirvonen, J; Nagren, T; Kajander, J; Hietala, J
   Measurement of cortical dopamine D-1 receptor binding with [C-11]SCH 23390: A test-retest analysis
   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
   
   J. Hirvonen et al., "Measurement of cortical dopamine D-1 receptor binding with [C-11]SCH 23390: A test-retest analysis", J CEREBR B, 21(10), 2001, pp. 1146-1150
5. Kaasinen, V; Nagren, K; Hietala, J; Farde, L; Rinne, JO
   Sex differences in extrastriatal dopamine D-2-like receptors in the human brain
   AMERICAN JOURNAL OF PSYCHIATRY
   
   V. Kaasinen et al., "Sex differences in extrastriatal dopamine D-2-like receptors in the human brain", AM J PSYCHI, 158(2), 2001, pp. 308-311
6. Laakso, A; Hietala, J
   Detachment and generalized social phobia - Drs. Laakso and Hietala reply
   AMERICAN JOURNAL OF PSYCHIATRY
   
   A. Laakso e J. Hietala, "Detachment and generalized social phobia - Drs. Laakso and Hietala reply", AM J PSYCHI, 158(2), 2001, pp. 327-328
7. Hietala, J; Kuoppamaki, M; Majasuo, H; Palvimaki, EP; Laakso, A; Syvalahti, E
   Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist butnot antagonist binding to 5-HT2c receptors after chronic treatment
   PSYCHOPHARMACOLOGY
   
   J. Hietala et al., "Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist butnot antagonist binding to 5-HT2c receptors after chronic treatment", PSYCHOPHAR, 157(2), 2001, pp. 180-187
8. Laakso, A; Hietala, J
   PET studies of brain monoamine transporters
   CURRENT PHARMACEUTICAL DESIGN
   
   A. Laakso e J. Hietala, "PET studies of brain monoamine transporters", CUR PHARM D, 6(16), 2000, pp. 1611-1623
9. Oikonen, V; Allonen, T; Nagren, K; Kajander, J; Hietala, J
   Quantification of [carbonyl-C-11]WAY-100635 binding: Considerations on thecerebellum
   NUCLEAR MEDICINE AND BIOLOGY
   
   V. Oikonen et al., "Quantification of [carbonyl-C-11]WAY-100635 binding: Considerations on thecerebellum", NUCL MED BI, 27(5), 2000, pp. 483-486
10. Syvalahti, EKG; Rakkolainen, V; Aaltonen, J; Lehtinen, V; Hietala, J
    Striatal D-2 dopamine receptor density and psychotic symptoms in schizophrenia: a longitudinal study
    SCHIZOPHRENIA RESEARCH
    
    E.K.G. Syvalahti et al., "Striatal D-2 dopamine receptor density and psychotic symptoms in schizophrenia: a longitudinal study", SCHIZOPHR R, 43(2-3), 2000, pp. 159-161
11. Vilkman, H; Kajander, J; Nagren, K; Oikonen, V; Syvalahti, E; Hietala, J
    Measurement of extrastriatal D-2-like receptor binding with [C-11]FLB 457 - a test-retest analysis
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    
    H. Vilkman et al., "Measurement of extrastriatal D-2-like receptor binding with [C-11]FLB 457 - a test-retest analysis", EUR J NUCL, 27(11), 2000, pp. 1666-1673
12. Kaasinen, V; Vilkman, H; Hietala, J; Nagren, K; Helenius, H; Olsson, H; Farde, L; Rinne, JO
    Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain
    NEUROBIOLOGY OF AGING
    
    V. Kaasinen et al., "Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain", NEUROBIOL A, 21(5), 2000, pp. 683-688
13. Hallikainen, T; Lachman, H; Saito, T; Volavka, J; Kauhanen, J; Salonen, JT; Ryynanen, OP; Koulu, M; Karvonen, MK; Pohjalainen, T; Syvalahti, E; Hietala, J; Tiihonen, J
    Lack of association between the functional variant of the catechol-o-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior
    AMERICAN JOURNAL OF MEDICAL GENETICS
    
    T. Hallikainen et al., "Lack of association between the functional variant of the catechol-o-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior", AM J MED G, 96(3), 2000, pp. 348-352
14. Kaasinen, V; Nagren, K; Hietala, J; Oikonen, V; Vilkman, H; Farde, L; Halldin, C; Rinne, JO
    Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease
    NEUROLOGY
    
    V. Kaasinen et al., "Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease", NEUROLOGY, 54(7), 2000, pp. 1482-1487
15. Salokangas, RKR; Vilkman, H; Ilonen, T; Taiminen, T; Bergman, J; Haaparanta, M; Solin, O; Alanen, A; Syvalahti, E; Hietala, J
    High levels of dopamine activity in the basal ganglia of cigarette smokers
    AMERICAN JOURNAL OF PSYCHIATRY
    
    R.K.R. Salokangas et al., "High levels of dopamine activity in the basal ganglia of cigarette smokers", AM J PSYCHI, 157(4), 2000, pp. 632-634
16. Laakso, A; Vilkman, H; Alakare, B; Haaparanta, M; Bergman, J; Solin, O; Peurasaari, J; Rakkolainen, V; Syvalahti, E; Hietala, J
    Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography
    AMERICAN JOURNAL OF PSYCHIATRY
    
    A. Laakso et al., "Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography", AM J PSYCHI, 157(2), 2000, pp. 269-271
17. Laakso, A; Vilkman, H; Kajander, J; Bergman, J; Haaparanta, M; Solin, O; Hietala, J
    Prediction of detached personality in healthy subjects by low dopamine transporter binding
    AMERICAN JOURNAL OF PSYCHIATRY
    
    A. Laakso et al., "Prediction of detached personality in healthy subjects by low dopamine transporter binding", AM J PSYCHI, 157(2), 2000, pp. 290-292
18. Hallikainen, T; Saito, T; Lachman, HM; Volavka, J; Pohjalainen, T; Ryynanen, OP; Kauhanen, J; Syvalahti, E; Hietala, J; Tiihonen, J
    Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior
    MOLECULAR PSYCHIATRY
    
    T. Hallikainen et al., "Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior", MOL PSYCHI, 4(4), 1999, pp. 385-388
19. Tiihonen, J; Hallikainen, T; Lachman, H; Saito, T; Volavka, J; Kauhanen, J; Salonen, JT; Ryynanen, OP; Koulu, M; Karvonen, MK; Pohjalainen, T; Syvalahti, E; Hietala, J
    Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism
    MOLECULAR PSYCHIATRY
    
    J. Tiihonen et al., "Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism", MOL PSYCHI, 4(3), 1999, pp. 286-289
20. Pohjalainen, T; Nagren, K; Syvalahti, EKG; Hietala, J
    The dopamine D-2 receptor 5 '-flanking variant, C-141 Ins/Del, is not associated with reduced dopamine D-2 receptor density in vivo
    PHARMACOGENETICS
    
    T. Pohjalainen et al., "The dopamine D-2 receptor 5 '-flanking variant, C-141 Ins/Del, is not associated with reduced dopamine D-2 receptor density in vivo", PHARMACOGEN, 9(4), 1999, pp. 505-509
21. Hietala, J; Syvalahti, E; Vilkman, H; Vuorio, K; Rakkolainen, V; Bergman, J; Haaparanta, M; Solin, O; Kuoppamaki, M; Eronen, E; Ruotsalainen, U; Salokangas, RKR
    Depressive symptoms and presynaptic dopamine function in neuroleptic-naiveschizophrenia
    SCHIZOPHRENIA RESEARCH
    
    J. Hietala et al., "Depressive symptoms and presynaptic dopamine function in neuroleptic-naiveschizophrenia", SCHIZOPHR R, 35(1), 1999, pp. 41-50
22. Hietala, J
    Ligand-receptor interactions studied by PET: implications for drug development
    ANNALS OF MEDICINE
    
    J. Hietala, "Ligand-receptor interactions studied by PET: implications for drug development", ANN MED, 31(6), 1999, pp. 438-443
23. Halsas, M; Hietala, J; Veski, P; Jurjenson, H; Marvola, M
    Morning versus evening dosing of ibuprofen using conventional and time-controlled release formulations
    INTERNATIONAL JOURNAL OF PHARMACEUTICS
    
    M. Halsas et al., "Morning versus evening dosing of ibuprofen using conventional and time-controlled release formulations", INT J PHARM, 189(2), 1999, pp. 179-185
24. Hietala, J; Nagren, K; Lehikoinen, P; Ruotsalainen, U; Syvalahti, E
    Measurement of striatal D-2 dopamine receptor density and affinity with [C-11]-raclopride in vivo: A test-retest analysis
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    
    J. Hietala et al., "Measurement of striatal D-2 dopamine receptor density and affinity with [C-11]-raclopride in vivo: A test-retest analysis", J CEREBR B, 19(2), 1999, pp. 210-217
25. Reinikainen, M; Hietala, J; Walls, M
    Reproductive allocation in Daphnia exposed to toxic cyanobacteria
    JOURNAL OF PLANKTON RESEARCH
    
    M. Reinikainen et al., "Reproductive allocation in Daphnia exposed to toxic cyanobacteria", J PLANK RES, 21(8), 1999, pp. 1553-1564
26. Kanerva, H; Vilkman, H; Nagren, K; Kilkku, O; Kuoppamaki, M; Syvalahti, E; Hietala, J
    Brain 5-HT2A receptor occupancy of deramciclane in humans after a single oral administration - a positron emission tomography study
    PSYCHOPHARMACOLOGY
    
    H. Kanerva et al., "Brain 5-HT2A receptor occupancy of deramciclane in humans after a single oral administration - a positron emission tomography study", PSYCHOPHAR, 145(1), 1999, pp. 76-81
27. POHJALAINEN T; RINNE JO; NAGREN K; LEHIKOINEN P; ANTTILA K; SYVALAHTI EKG; HIETALA J
    THE A1 ALLELE OF THE HUMAN D-2 DOPAMINE-RECEPTOR GENE PREDICTS LOW D-2 RECEPTOR AVAILABILITY IN HEALTHY-VOLUNTEERS
    Molecular psychiatry
    
    T. Pohjalainen et al., "THE A1 ALLELE OF THE HUMAN D-2 DOPAMINE-RECEPTOR GENE PREDICTS LOW D-2 RECEPTOR AVAILABILITY IN HEALTHY-VOLUNTEERS", Molecular psychiatry, 3(3), 1998, pp. 256-260
28. TIIHONEN J; VILKMAN H; RASANEN P; RYYNANEN OP; HAKKO H; BERGMAN J; HAMALAINEN T; LAAKSO A; HAAPARANTASOLIN M; SOLIN O; KUOPPAMAKI M; SYVALAHTI E; HIETALA J
    STRIATAL PRESYNAPTIC DOPAMINE FUNCTION IN TYPE-1 ALCOHOLICS MEASURED WITH POSITRON-EMISSION-TOMOGRAPHY
    Molecular psychiatry
    
    J. Tiihonen et al., "STRIATAL PRESYNAPTIC DOPAMINE FUNCTION IN TYPE-1 ALCOHOLICS MEASURED WITH POSITRON-EMISSION-TOMOGRAPHY", Molecular psychiatry, 3(2), 1998, pp. 156-161
29. LAAKSO A; BERGMAN J; HAAPARANTA M; VILKMAN H; SOLIN O; HIETALA J
    [F-18] CFT ([F-18]WIN-35,428), A RADIOLIGAND TO STUDY THE DOPAMINE TRANSPORTER WITH PET - CHARACTERIZATION IN HUMAN-SUBJECTS
    Synapse
    
    A. Laakso et al., "[F-18] CFT ([F-18]WIN-35,428), A RADIOLIGAND TO STUDY THE DOPAMINE TRANSPORTER WITH PET - CHARACTERIZATION IN HUMAN-SUBJECTS", Synapse, 28(3), 1998, pp. 244-250
30. LAAKSO A; VILKMAN H; ALAKARE B; HAAPARANTA M; BERGMAN J; SOLIN O; PEURASAARI J; RAKKOLAINEN V; SYVALAHTI EKG; HIETALA J
    ABNORMAL ASYMMETRY OF DOPAMINERGIC NERVE-TERMINALS IN THE CAUDATE-NUCLEUS OF NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS
    Nordic journal of psychiatry
    
    A. Laakso et al., "ABNORMAL ASYMMETRY OF DOPAMINERGIC NERVE-TERMINALS IN THE CAUDATE-NUCLEUS OF NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS", Nordic journal of psychiatry, 52(2), 1998, pp. 103-104
31. KAJANDER J; VILKMAN H; SYVALAHTI E; NAGREN K; HIETALA J
    EFFECTS OF REPEATED FLUOXETINE TREATMENT ON STRIATAL D-2 DOPAMINE BINDING IN HUMANS, MEASURED WITH POSITRON-EMISSION-TOMOGRAPHY
    Nordic journal of psychiatry
    
    J. Kajander et al., "EFFECTS OF REPEATED FLUOXETINE TREATMENT ON STRIATAL D-2 DOPAMINE BINDING IN HUMANS, MEASURED WITH POSITRON-EMISSION-TOMOGRAPHY", Nordic journal of psychiatry, 52(2), 1998, pp. 121-122
32. KARLSSON H; HIETALA J; SAARIJARVI S
    ACUTE PARANOID-HALLUCINATORY PSYCHOSIS AFTER AN OVERDOSE OF FLUOXETINE AND ENALAPRIL - A CASE-REPORT
    Nordic journal of psychiatry
    
    H. Karlsson et al., "ACUTE PARANOID-HALLUCINATORY PSYCHOSIS AFTER AN OVERDOSE OF FLUOXETINE AND ENALAPRIL - A CASE-REPORT", Nordic journal of psychiatry, 52(2), 1998, pp. 153-154
33. HIETALA J
    IMAGING OF THE DOPAMINERGIC PATHWAYS IN SCHIZOPHRENIA
    Nordic journal of psychiatry
    
    J. Hietala, "IMAGING OF THE DOPAMINERGIC PATHWAYS IN SCHIZOPHRENIA", Nordic journal of psychiatry, 52, 1998, pp. 64-64
34. ITO H; HIETALA J; BLOMQVIST G; HALLDIN C; FARDE L
    COMPARISON OF THE TRANSIENT EQUILIBRIUM AND CONTINUOUS-INFUSION METHOD FOR QUANTITATIVE PET ANALYSIS OF [C-11] RACLOPRIDE BINDING
    Journal of cerebral blood flow and metabolism
    
    H. Ito et al., "COMPARISON OF THE TRANSIENT EQUILIBRIUM AND CONTINUOUS-INFUSION METHOD FOR QUANTITATIVE PET ANALYSIS OF [C-11] RACLOPRIDE BINDING", Journal of cerebral blood flow and metabolism, 18(9), 1998, pp. 941-950
35. TIIHONEN J; HALLIKAINEN T; LACHMAN H; VOLAVKA J; HIETALA J; POHJALAINEN T; RYYNANEN OP; KAUHANEN J
    ASSOCIATION BETWEEN THE GENETIC-POLYMORPHISM OF THE OF THE CATECHOL-O-METHYLTRANSFERASE (COMT) AND TYPE-1 ALCOHOLISM
    American journal of medical genetics
    
    J. Tiihonen et al., "ASSOCIATION BETWEEN THE GENETIC-POLYMORPHISM OF THE OF THE CATECHOL-O-METHYLTRANSFERASE (COMT) AND TYPE-1 ALCOHOLISM", American journal of medical genetics, 81(6), 1998, pp. 516-516
36. REINIKAINEN M; HIETALA J; WALLS M
    ADAPTATIONS AND RESISTANCE OF ZOOPLANKTON TO STRESS - EFFECTS OF GENETIC, ENVIRONMENTAL, AND PHYSIOLOGICAL FACTORS
    Ecotoxicology and environmental safety
    
    M. Reinikainen et al., "ADAPTATIONS AND RESISTANCE OF ZOOPLANKTON TO STRESS - EFFECTS OF GENETIC, ENVIRONMENTAL, AND PHYSIOLOGICAL FACTORS", Ecotoxicology and environmental safety, 40(1-2), 1998, pp. 77-80
37. POHJALAINEN T; RINNE JO; NAGREN K; SYVALAHTI E; HIETALA J
    SEX-DIFFERENCES IN THE STRIATAL DOPAMINE D-2 RECEPTOR-BINDING CHARACTERISTICS IN-VIVO
    The American journal of psychiatry
    
    T. Pohjalainen et al., "SEX-DIFFERENCES IN THE STRIATAL DOPAMINE D-2 RECEPTOR-BINDING CHARACTERISTICS IN-VIVO", The American journal of psychiatry, 155(6), 1998, pp. 768-773
38. PALVIMAKI EP; MAJASUO H; KUOPPAMAKI M; MANNISTO PT; SYVALAHTI E; HIETALA J
    DERAMCICLANE, A PUTATIVE ANXIOLYTIC DRUG, IS A SEROTONIN 5-HT2C RECEPTOR INVERSE AGONIST BUT FAILS TO INDUCE 5-HT2C RECEPTOR DOWN-REGULATION
    Psychopharmacology
    
    E.P. Palvimaki et al., "DERAMCICLANE, A PUTATIVE ANXIOLYTIC DRUG, IS A SEROTONIN 5-HT2C RECEPTOR INVERSE AGONIST BUT FAILS TO INDUCE 5-HT2C RECEPTOR DOWN-REGULATION", Psychopharmacology, 136(2), 1998, pp. 99-104
39. SALONEN I; HIETALA J; LAIHINEN A; LEHIKOINEN P; LEINO L; NAGREN K; RUOTSALAINEN U; OIKONEN V; TUOKKOLA T; NANTO V
    A PET STUDY ON THE ACUTE EFFECT OF ETHANOL ON STRIATAL D2 DOPAMINE-RECEPTORS WITH [C-11] RACLOPRIDE IN HEALTHY-MALES
    Human psychopharmacology
    
    I. Salonen et al., "A PET STUDY ON THE ACUTE EFFECT OF ETHANOL ON STRIATAL D2 DOPAMINE-RECEPTORS WITH [C-11] RACLOPRIDE IN HEALTHY-MALES", Human psychopharmacology, 12(2), 1997, pp. 145-152
40. GACSALYI I; SCHMIDT E; GYERTYAN I; VASAR E; LANG A; HAAPALINNA A; FEKETE M; HIETALA J; SYVALAHTI E; TUOMAINEN P; MANNISTO PT
    RECEPTOR-BINDING PROFILE AND ANXIOLYTIC-TYPE ACTIVITY OF DERAMCICLANE(EGIS-3886) IN ANIMAL-MODELS
    Drug development research
    
    I. Gacsalyi et al., "RECEPTOR-BINDING PROFILE AND ANXIOLYTIC-TYPE ACTIVITY OF DERAMCICLANE(EGIS-3886) IN ANIMAL-MODELS", Drug development research, 40(4), 1997, pp. 333-348
41. HIETALA J; LAURENMAATTA C; WALLS M
    LIFE-HISTORY RESPONSES OF DAPHNIA CLONES TO TOXIC MICROCYSTIS AT DIFFERENT FOOD LEVELS
    Journal of plankton research
    
    J. Hietala et al., "LIFE-HISTORY RESPONSES OF DAPHNIA CLONES TO TOXIC MICROCYSTIS AT DIFFERENT FOOD LEVELS", Journal of plankton research, 19(7), 1997, pp. 917-926
42. KORPELAINEN H; KETOLA M; HIETALA J
    SOMATIC POLYPLOIDY EXAMINED BY FLOW-CYTOMETRY IN DAPHNIA
    Journal of plankton research
    
    H. Korpelainen et al., "SOMATIC POLYPLOIDY EXAMINED BY FLOW-CYTOMETRY IN DAPHNIA", Journal of plankton research, 19(12), 1997, pp. 2031-2040
43. LAURENMAATTA C; HIETALA J; WALLS M
    RESPONSES OF DAPHNIA-PULEX POPULATIONS TO TOXIC CYANOBACTERIA
    Freshwater Biology
    
    C. Laurenmaatta et al., "RESPONSES OF DAPHNIA-PULEX POPULATIONS TO TOXIC CYANOBACTERIA", Freshwater Biology, 37(3), 1997, pp. 635-647
44. HIETALA J; LAURENMAATTA C; WALLS M
    SENSITIVITY OF DAPHNIA TO TOXIC CYANOBACTERIA - EFFECTS OF GENOTYPE AND TEMPERATURE
    Freshwater Biology
    
    J. Hietala et al., "SENSITIVITY OF DAPHNIA TO TOXIC CYANOBACTERIA - EFFECTS OF GENOTYPE AND TEMPERATURE", Freshwater Biology, 37(2), 1997, pp. 299-306
45. POHJALAINEN T; CRAVCHIK A; GEJMAN PV; RINNE J; NAGREN K; SYVALAHTI E; HIETALA J
    ANTAGONIST BINDING CHARACTERISTICS OF THE SER(311)-]CYS VARIANT OF HUMAN DOPAMINE D-2 RECEPTOR IN-VIVO AND IN-VITRO
    Biochemical and biophysical research communications
    
    T. Pohjalainen et al., "ANTAGONIST BINDING CHARACTERISTICS OF THE SER(311)-]CYS VARIANT OF HUMAN DOPAMINE D-2 RECEPTOR IN-VIVO AND IN-VITRO", Biochemical and biophysical research communications, 232(1), 1997, pp. 143-146
46. POHJALAINEN T; RINNE JO; NAGREN K; SYVALAHTI EKG; PELTONEN L; HIETALA J
    HUMAN D-2 DOPAMINE-RECEPTOR GENE POLYMORPHISMS AND BINDING CHARACTERISTICS IN-VIVO
    American journal of human genetics
    
    T. Pohjalainen et al., "HUMAN D-2 DOPAMINE-RECEPTOR GENE POLYMORPHISMS AND BINDING CHARACTERISTICS IN-VIVO", American journal of human genetics, 61(4), 1997, pp. 1700-1700
47. FARDE L; SUHARA T; NYBERG S; KARLSSON P; NAKASHIMA Y; HIETALA J; HALLDIN C
    A PET STUDY OF [C-11]FLB-457 BINDING TO EXTRASTRIATAL D-2-DOPAMINE RECEPTORS IN HEALTHY-SUBJECTS AND ANTIPSYCHOTIC DRUG-TREATED PATIENTS
    Psychopharmacology
    
    L. Farde et al., "A PET STUDY OF [C-11]FLB-457 BINDING TO EXTRASTRIATAL D-2-DOPAMINE RECEPTORS IN HEALTHY-SUBJECTS AND ANTIPSYCHOTIC DRUG-TREATED PATIENTS", Psychopharmacology, 133(4), 1997, pp. 396-404
48. HIETALA J; KUOPPAMAKI M; NAGREN K; LEHIKOINEN P; SYVALAHTI E
    EFFECTS OF LORAZEPAM ADMINISTRATION ON STRIATAL DOPAMINE D-2 RECEPTOR-BINDING CHARACTERISTICS IN MAN - A POSITRON EMISSION TOMOGRAPHY STUDY
    Psychopharmacology
    
    J. Hietala et al., "EFFECTS OF LORAZEPAM ADMINISTRATION ON STRIATAL DOPAMINE D-2 RECEPTOR-BINDING CHARACTERISTICS IN MAN - A POSITRON EMISSION TOMOGRAPHY STUDY", Psychopharmacology, 132(4), 1997, pp. 361-365
49. LAAKSO A; PALVIMAKI EP; KUOPPAMAKI M; SYVALAHTI E; HIETALA J
    CHRONIC CITALOPRAM AND FLUOXETINE TREATMENTS UP-REGULATE 5-HT2C RECEPTORS IN THE RAT CHOROID-PLEXUS
    Neuropsychopharmacology
    
    A. Laakso et al., "CHRONIC CITALOPRAM AND FLUOXETINE TREATMENTS UP-REGULATE 5-HT2C RECEPTORS IN THE RAT CHOROID-PLEXUS", Neuropsychopharmacology, 15(2), 1996, pp. 143-151
50. HAAPARANTA M; BERGMAN J; LAAKSO A; HIETALA J; SOLIN O
    [F-18]CFT ([F-18]WIN-35,428), A RADIOLIGAND TO STUDY THE DOPAMINE TRANSPORTER WITH PET - BIODISTRIBUTION IN RATS
    Synapse
    
    M. Haaparanta et al., "[F-18]CFT ([F-18]WIN-35,428), A RADIOLIGAND TO STUDY THE DOPAMINE TRANSPORTER WITH PET - BIODISTRIBUTION IN RATS", Synapse, 23(4), 1996, pp. 321-327
51. HIETALA J; SYVALAHTI E
    DOPAMINE IN SCHIZOPHRENIA
    Annals of medicine
    
    J. Hietala e E. Syvalahti, "DOPAMINE IN SCHIZOPHRENIA", Annals of medicine, 28(6), 1996, pp. 557-561
52. WONG G; KUOPPAMAKI M; HIETALA J; LUDDENS H; SYVALAHTI E; KORPI ER
    EFFECTS OF CLOZAPINE METABOLITES AND CHRONIC CLOZAPINE TREATMENT ON RAT-BRAIN GABA(A) RECEPTORS
    European journal of pharmacology
    
    G. Wong et al., "EFFECTS OF CLOZAPINE METABOLITES AND CHRONIC CLOZAPINE TREATMENT ON RAT-BRAIN GABA(A) RECEPTORS", European journal of pharmacology, 314(3), 1996, pp. 319-323
53. TIIHONEN J; KUOPPAMAKI M; NAGREN K; BERGMAN J; ERONEN E; SYVALAHTI E; HIETALA J
    SEROTONERGIC MODULATION OF STRIATAL D-2 DOPAMINE-RECEPTOR BINDING IN HUMANS MEASURED WITH POSITRON EMISSION TOMOGRAPHY
    Psychopharmacology
    
    J. Tiihonen et al., "SEROTONERGIC MODULATION OF STRIATAL D-2 DOPAMINE-RECEPTOR BINDING IN HUMANS MEASURED WITH POSITRON EMISSION TOMOGRAPHY", Psychopharmacology, 126(4), 1996, pp. 277-280
54. PALVIMAKI EP; ROTH BL; MAJASUO H; LAAKSO A; KUOPPAMAKI M; SYVALAHTI E; HIETALA J
    INTERACTIONS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS WITH THE SEROTONIN 5-HT2C RECEPTOR
    Psychopharmacology
    
    E.P. Palvimaki et al., "INTERACTIONS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS WITH THE SEROTONIN 5-HT2C RECEPTOR", Psychopharmacology, 126(3), 1996, pp. 234-240
55. UHARI M; HIETALA J; TUOKKO H
    RISK OF ACUTE OTITIS-MEDIA IN RELATION TO THE VIRAL ETIOLOGY OF INFECTIONS IN CHILDREN
    Clinical infectious diseases
    
    M. Uhari et al., "RISK OF ACUTE OTITIS-MEDIA IN RELATION TO THE VIRAL ETIOLOGY OF INFECTIONS IN CHILDREN", Clinical infectious diseases, 20(3), 1995, pp. 521-524
56. KUOPPAMAKI M; PALVIMAKI EP; HIETALA J; SYVALAHTI E
    DIFFERENTIAL REGULATION OF RAT 5-HT2A AND 5-HT2C RECEPTORS AFTER CHRONIC TREATMENT WITH CLOZAPINE, CHLORPROMAZINE AND 3 PUTATIVE ATYPICAL ANTIPSYCHOTIC-DRUGS
    Neuropsychopharmacology
    
    M. Kuoppamaki et al., "DIFFERENTIAL REGULATION OF RAT 5-HT2A AND 5-HT2C RECEPTORS AFTER CHRONIC TREATMENT WITH CLOZAPINE, CHLORPROMAZINE AND 3 PUTATIVE ATYPICAL ANTIPSYCHOTIC-DRUGS", Neuropsychopharmacology, 13(2), 1995, pp. 139-150
57. RANTALA H; UHARI M; HIETALA J
    FACTORS TRIGGERING THE FIRST FEBRILE SEIZURE
    Acta paediatrica
    
    H. Rantala et al., "FACTORS TRIGGERING THE FIRST FEBRILE SEIZURE", Acta paediatrica, 84(4), 1995, pp. 407-410
58. UHARI M; NIEMELA M; HIETALA J
    PREDICTION OF ACUTE OTITIS-MEDIA WITH SYMPTOMS AND SIGNS
    Acta paediatrica
    
    M. Uhari et al., "PREDICTION OF ACUTE OTITIS-MEDIA WITH SYMPTOMS AND SIGNS", Acta paediatrica, 84(1), 1995, pp. 90-92
59. HIETALA J; REINIKAINEN M; WALLS M
    VARIATION IN LIFE-HISTORY RESPONSES OF DAPHNIA TO TOXIC MICROCYSTIS-AERUGINOSA
    Journal of plankton research
    
    J. Hietala et al., "VARIATION IN LIFE-HISTORY RESPONSES OF DAPHNIA TO TOXIC MICROCYSTIS-AERUGINOSA", Journal of plankton research, 17(12), 1995, pp. 2307-2318
60. HIETALA J; SYVALAHTI E; VUORIO K; RAKKOLAINEN V; BERGMAN J; HAAPARANTA M; SOLIN O; KUOPPAMAKI M; KIRVELA O; RUOTSALAINEN U; SALOKANGAS RKR
    PRESYNAPTIC DOPAMINE FUNCTION IN STRIATUM OF NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS
    Lancet
    
    J. Hietala et al., "PRESYNAPTIC DOPAMINE FUNCTION IN STRIATUM OF NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS", Lancet, 346(8983), 1995, pp. 1130-1131
61. HIETALA J; VALTONEN ET; AALTONEN T
    EXPERIMENTAL-INFECTION OF BROWN TROUT, SALMO-TRUTTA L, USING A FINNISH YERSINIA-RUCKERI ISOLATE
    Aquaculture
    
    J. Hietala et al., "EXPERIMENTAL-INFECTION OF BROWN TROUT, SALMO-TRUTTA L, USING A FINNISH YERSINIA-RUCKERI ISOLATE", Aquaculture, 136(1-2), 1995, pp. 11-20
62. LAURENMAATTA C; HIETALA J; REINIKAINEN M; WALLS M
    DO MICROCYSTIS-AERUGINOSA TOXINS ACCUMULATE IN THE FOOD-WEB - A LABORATORY STUDY
    Hydrobiologia
    
    C. Laurenmaatta et al., "DO MICROCYSTIS-AERUGINOSA TOXINS ACCUMULATE IN THE FOOD-WEB - A LABORATORY STUDY", Hydrobiologia, 304(1), 1995, pp. 23-27
63. KUOPPAMAKI M; SEPPALA T; SYVALAHTI E; HIETALA J
    REGULATION OF SEROTONIN 5-HT2C RECEPTORS IN THE RAT CHOROID-PLEXUS AFTER ACUTE CLOZAPINE TREATMENT
    European journal of pharmacology. Molecular pharmacology section
    
    M. Kuoppamaki et al., "REGULATION OF SEROTONIN 5-HT2C RECEPTORS IN THE RAT CHOROID-PLEXUS AFTER ACUTE CLOZAPINE TREATMENT", European journal of pharmacology. Molecular pharmacology section, 269(2), 1994, pp. 201-208
64. SYVALAHTI EKG; POHJALAINEN T; KORPI ER; PALVIMAKI EP; OVASKA T; KUOPPAMAKI M; HIETALA J
    DOPAMINE D-2 RECEPTOR GENE-EXPRESSION IN RAT LINES SELECTED FOR DIFFERENCES IN VOLUNTARY ALCOHOL-CONSUMPTION
    Alcoholism, clinical and experimental research
    
    E.K.G. Syvalahti et al., "DOPAMINE D-2 RECEPTOR GENE-EXPRESSION IN RAT LINES SELECTED FOR DIFFERENCES IN VOLUNTARY ALCOHOL-CONSUMPTION", Alcoholism, clinical and experimental research, 18(4), 1994, pp. 1029-1031
65. HIETALA J; ROOT A; KNUUTTILA P
    THE SURFACE-ACIDITY OF PURE AND MODIFIED ALUMINAS IN RE AL2O3 METATHESIS CATALYSTS AS STUDIED BY H-1 MAS NMR-SPECTROSCOPY AND ITS IMPORTANCE IN THE ETHENOLYSIS OF 1,5-CYCLOOCTADIENE/
    Journal of catalysis
    
    J. Hietala et al., "THE SURFACE-ACIDITY OF PURE AND MODIFIED ALUMINAS IN RE AL2O3 METATHESIS CATALYSTS AS STUDIED BY H-1 MAS NMR-SPECTROSCOPY AND ITS IMPORTANCE IN THE ETHENOLYSIS OF 1,5-CYCLOOCTADIENE/", Journal of catalysis, 150(1), 1994, pp. 46-55
66. KUOPPAMAKI M; PALVIMAKI EP; SYVALAHTI E; HIETALA J
    5-HT1C RECEPTOR-MEDIATED PHOSPHOINOSITIDE HYDROLYSIS IN THE RAT CHOROID-PLEXUS AFTER CHRONIC TREATMENT WITH CLOZAPINE
    European journal of pharmacology
    
    M. Kuoppamaki et al., "5-HT1C RECEPTOR-MEDIATED PHOSPHOINOSITIDE HYDROLYSIS IN THE RAT CHOROID-PLEXUS AFTER CHRONIC TREATMENT WITH CLOZAPINE", European journal of pharmacology, 255(1-3), 1994, pp. 91-97
67. HIETALA J; SYVALAHTI E; VUORIO K; NAGREN K; LEHIKOINEN P; RUOTSALAINEN U; RAKKOLAINEN V; LEHTINEN V; WEGELIUS U
    STRIATAL D-2, DOPAMINE-RECEPTOR CHARACTERISTICS IN NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS STUDIED WITH POSITRON EMISSION TOMOGRAPHY
    Archives of general psychiatry
    
    J. Hietala et al., "STRIATAL D-2, DOPAMINE-RECEPTOR CHARACTERISTICS IN NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS STUDIED WITH POSITRON EMISSION TOMOGRAPHY", Archives of general psychiatry, 51(2), 1994, pp. 116-123
68. HIETALA J; WEST C; SYVALAHTI E; NAGREN K; LEHIKOINEN P; SONNINEN P; RUOTSALAINEN U
    STRIATAL D-2 DOPAMINE-RECEPTOR BINDING CHARACTERISTICS IN-VIVO IN PATIENTS WITH ALCOHOL DEPENDENCE
    Psychopharmacology
    
    J. Hietala et al., "STRIATAL D-2 DOPAMINE-RECEPTOR BINDING CHARACTERISTICS IN-VIVO IN PATIENTS WITH ALCOHOL DEPENDENCE", Psychopharmacology, 116(3), 1994, pp. 285-290
69. PALVIMAKI EP; LAAKSO A; KUOPPAMAKI M; SYVALAHTI E; HIETALA J
    UP-REGULATION OF BETA(1)-ADRENERGIC RECEPTORS IN RAT-BRAIN AFTER CHRONIC CITALOPRAM AND FLUOXETINE TREATMENTS
    Psychopharmacology
    
    E.P. Palvimaki et al., "UP-REGULATION OF BETA(1)-ADRENERGIC RECEPTORS IN RAT-BRAIN AFTER CHRONIC CITALOPRAM AND FLUOXETINE TREATMENTS", Psychopharmacology, 115(4), 1994, pp. 543-546
70. KUOPPAMAKI M; SYVALAHTI E; HIETALA J
    CLOZAPINE AND N-DESMETHYLCLOZAPINE ARE POTENT 5-HT(1C) RECEPTOR ANTAGONISTS
    European journal of pharmacology. Molecular pharmacology section
    
    M. Kuoppamaki et al., "CLOZAPINE AND N-DESMETHYLCLOZAPINE ARE POTENT 5-HT(1C) RECEPTOR ANTAGONISTS", European journal of pharmacology. Molecular pharmacology section, 245(2), 1993, pp. 179-182